Report      Database

    Genetic Testing Market and Forecast - Global Analysis 2010 - 2015

    Date: 14 Nov, 2011              Type: Life Science              Pages: 57

    Genetic Testing Market and Forecast - Global Analysis 2010 - 2015
    • Electronic Access - Single User License
      $1,000.00
    • CD-ROM Mail Delivery
      $1,100.00
    • Hard-copy Mail Delivery
      $1,100.00
    • Hard-copy Mail Delivery
      $1,600.00

    Genetic Testing - Market Overview

    The genetic testing market is witnessing a period of profound growth. Growing with a CAGR of 18 percent globally genetic testing market is expected to cross the figure of US$ 10 Billion by 2015. This significant growth is primarily attributed to the incidence of genetic diseases, burgeoning demand for molecular diagnostics, aging population, and subsequent increase in chronic diseases. Increasing knowledge about the potential benefits in genetic testing has been one of the prime reasons for the growth in genetic testing.

    Pharmacogenomics is the most lucrative segment of genetic testing. Cancer genetic testing should post strong position in the genetic testing industry due to rising cases of cancer patients with the market share of around 23% in 2010 and it is expected that cancer genetic testing will lead the genetic testing market by 2015. The future growth in genetic testing is expected to come from prenatal and predisposition genetic testing.

    Genetic testing is becoming an integral and growing part of healthcare provision and services.
    Advancements in genetic testing, together with genetically engineered drugs, are expected to aid in tailoring personalized medicine for specific races, individuals, and families. The genetic testing sector will grow rapidly over the next 5 to 10 years and spread beyond the small number of specialist genetic centres. 


    Report Details

    “Genetic Testing Market and Forecast - Global Analysis 2010 – 2015” report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:

    •    Global Genetic Testing Market (2005 – 2015)
    •    Top 5 application wise genetic testing (Cancer Genetic Testing, Prenatal Genetic Testing, Predisposition Genetic Testing, Pharmacogenomics Genetic Testing) data  of Past, Present and Future Market
    •    United States immigration genetic testing market  
    •    Top Corporate past, present developments  
    •    Top Laboratory Merger & Acquisition deals from 2007 - 2009
    •    Driving forces for the growth of global genetic testing market
    •    Challenges faced by genetic testing market in the coming years
    •    Key Players analysis in the genetic testing market


    Research Highlights

    •    Globally, Genetic Testing market is expected to cross the figure of US$ 10 Billion by 2015
    •    Cancer Genetic testing dominates the Genetic Testing market with more than 35% market share by  2015
    •    Cancer Genetic Testing and Pharmacogenomics testing are likely growth leaders in the genetic testing market. 
    •    Prenatal & Predisposition genetic testing will have a combined market share of 26% by 2015


    Company Analysis

    This section covers the key facts about the major companies that play an important role in Genetic Testing Market. The companies analyzed in this section are – Orchid Cellmark Inc, 23andMe, Pathway Genomics Corporation, Navigenics, Decode Genetic. All the companies have been analyzed from two points of view 1) Strength of the company in genetic testing market 2) Weakness of the company in genetic testing market.


    Data Sources 

    This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

    Information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

    1.    Executive Summary
    2.    Global Genetic Testing Market
    3.    Genetic Testing Market Share & Future Forecast

    4.    Genetic Testing Market (Application Segment) 2005 – 2015
    4.1    Cancer Genetic Testing Market
    4.2    Prenatal Genetic Testing Market
    4.3    Predisposition Genetic Testing Market
    4.4    Pharmacogenomics Genetic Testing Market

    5.    Corporate Developments
    5.1    LabCorp to Buy Genzyme's Genetic Testing Unit
    5.2    DNA Testing Systems Inks Agreement with DNAPrint Genomics Inc. 
    5.3    Hologic to Acquire Third Wave Technologies
    5.4    PerkinElmer Acquires Newborn Metabolic Screening Assets of Pediatrix
    5.5    Affymetrix to Acquire Panomics
    6.    Laboratory Merger & Acquisition

    7.    Driving Forces for Genetic Testing
    7.1    Present Development and Future of Genetic Testing Market
    7.2    Increased Incidence of Cancer
    7.3    Emerging Economies is Expected to Drive the Market in Future
    7.4    Increasing Availability of Tests Allows More Patients to be Diagnosed
    7.5    Availability of Direct-to-Consumer Tests to Increase Test Volumes

    8.    Challenges for Genetic Testing
    8.1    Lack of a Coherent Oversight System to Ensure the Quality of Tests and Testing Laboratories
    8.2    Dearth of Professional Guidelines for Conducting Genetic Tests

    9.    Companies Analysis
    9.1    Orchid Cellmark Inc
    9.1.1    Strengths
    9.1.2    Weaknesses
    9.2    23andMe
    9.2.1    Strengths
    9.2.2    Weaknesses
    9.3    Pathway Genomics Corporation
    9.3.1    Strengths
    9.3.2    Weaknesses
    9.4    Navigenics
    9.4.1    Strengths
    9.4.2    Weaknesses
    9.5    deCODE Genetics
    9.5.1    Strengths
    9.5.2    Weaknesses

    List of Figures:

    Figure 2 1:  Global – Genetic Testing Market (Million US$), 2005 – 2010
    Figure 2 2: Global – Forecast for Genetic Testing Market (Million US$), 2011 – 2015
    Figure 3 1: Global – Genetic Testing Market Share (Percent), 2008 – 2010
    Figure 3 2: Global – Forecast for Genetic Testing Market Share (Percent), 2011 – 2015
    Figure 4 1: Global – Cancer Genetic Testing Market (Million US$), 2000 – 2010
    Figure 4 2: Global – Forecast for Cancer Genetic Testing Market (Million US$), 2011 – 2015
    Figure 4 3: Global – Prenatal Genetic Testing Market (Million US$), 2000 – 2010
    Figure 4 4: Global – Forecast for Prenatal Genetic Testing Market (Million US$), 2011 – 2015
    Figure 4 5: Global – Predisposition Genetic Testing Market (Million US$), 2000 – 2010
    Figure 4 6: Global – Forecast for Predisposition Genetic Testing Market (Million US$), 2011 – 2015
    Figure 4 7: Global – Pharmacogenomics Genetic Testing Market (Million US$), 2005 – 2010
    Figure 4 8: Global – Forecast for Pharmacogenomics Genetic Testing Market (Million US$), 2011 – 2015
    Figure 5 1: United States – Immigration Testing Market (Million US$), 2007 – 2010
    Figure 5 2: United States – Forecast for Immigration Testing Market (Million US$), 2011 – 2015
    Figure 8 1: BRIC – In Vitro Diagnostic Market (Billion US$), 2009 – 2010
    Figure 8 2: BRIC – Forecast for In Vitro Diagnostic Market (Billion US$), 2011 – 2015
    Figure 8 3: Global – Growth of Laboratory Directory (Number), 2000 – 2010
    Figure 8 5: Global – Direct to Consumer Genetic Testing Market (Million US$), 2008 – 2010
    Figure 8 6: Global – Forecast for Direct to Consumer Genetic Testing Market (Million US$), 2011 – 2015
    Figure 10 1: Orchid Cellmark Inc Laboratories – Key Financials (Million US$) 2007 – 2009

    List of Tables:

    Table 6 1: LabCorp & Genzyme Genetic – Acquisitions (Million US$), 2010
    Table 6 2: Hologic & Third Wave Technologies – Acquisitions (Million US$), 2008
    Table 6 3: PerkinElmer Inc & Pediatrix Medical Group – Acquisitions 2008
    Table 6 4: Affymetrix & Panomics – Acquisitions (Million US$), 2008
    Table 7 1: Global – Laboratory Merger & Acquisition (Million US$), January 2007 – July 2009
    Table 8 1: Global – New Cancer Cases & Deaths & Forecast (Million), 2000 & 2020
    Table 8 2: Global – All Cancers (excluding non-melanoma Skin Cancer) Incidence and Mortality (Thousand), 2008

     


    Related Products